Aster CMI Doctors Demonstrate an Effective Role in Brain Aneurysm Treatment

IMT News Desk
IMT News Desk
· 2 min read

The doctors at Aster CMI Hospital effectively treated a 55 year-old patient suffering from the severe problem of brain aneurysm and Sub Arachnoid Hemorrhage (SAH), also known as Brain Hemorrhage recently.  In a demonstration of path-breaking technology and commitment to save lives, the doctors at the hospital showcased how latest treatment methods in neurosurgery can play an effective role in brain hemorrhage treatment.

The patient was leading a completely normal life unaware of the fact that he was suffering from an aneurysm in one of the major blood vessels of brain. He was suffering from severe headaches and came to doctor with an altered sensorium. His family had taken him to various neurosurgeons across the city for treatment, but there was no solution. After imaging was conducted on him, he was diagnosed with SAH and was referred later to Aster CMI Hospital for treatment.

The Brain Angiogram (DSA) showed Blister Aneurysm in one of the major brain blood vessel (ICA), which is difficult to treat with open brain surgery. After a detailed case evaluation, the patient was treated by endovascular procedure by placing a Pipeline Flex Flow Diversion device in the diseased area.

Dr. Santhosh NU, Consultant, Neurosurgery & Endovascular Neurosurgery, said, “This is essentially a flow diversion device to treat complex giant aneurysms or blister aneurysms (in this case) that cannot be treated with a surgical clipping. A flow diverter seals the affected vessel, allowing the aneurysm to heal and reducing the risk of rupture.”

A brain aneurysm is a tiny bubble or bulge off the side of an artery on the brain’s surface. Over a period, due to high blood pressure, use of cigarettes or due to genetic predisposition, it weakens the arterial wall of an aneurysm that can become so thin that it bursts, spilling blood over the brain’s surface. Sub Arachnoid Hemorrhage (SAH) commonly called as Brain Hemorrhage is the most feared outcome of a brain aneurysm and is what drives the urgency in treating many brain aneurysms, even if found accidentally. Such cases are very serious because there is a high chance of another hemorrhage, which can prove to be fatal. The common symptoms of brain hemorrhage can include sudden and severe headache, problems with vision, loss of balance or coordination, sudden tingling, weakness, numbness or paralysis of the face, arm, or leg.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk